| MeSH term | MeSH ID | Detail |
|---|---|---|
| Frontal Sinusitis | D015522 | 1 associated lipids |
| Paratyphoid Fever | D010284 | 1 associated lipids |
| Asymptomatic Infections | D058345 | 1 associated lipids |
| Hyper-IgM Immunodeficiency Syndrome | D053306 | 1 associated lipids |
| Ectodermal Dysplasia | D004476 | 1 associated lipids |
| Aphasia, Broca | D001039 | 1 associated lipids |
| T-Lymphocytopenia, Idiopathic CD4-Positive | D018344 | 1 associated lipids |
| Acquired Hyperostosis Syndrome | D020083 | 1 associated lipids |
| Myelitis, Transverse | D009188 | 1 associated lipids |
| Epiglottitis | D004826 | 1 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Salimi A et al. | Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect. | 2016 | Xenobiotica | pmid:26068526 |
| Martande SS et al. | Clinical and microbiological effects of systemic azithromycin in adjunct to nonsurgical periodontal therapy in treatment of Aggregatibacter actinomycetemcomitans associated periodontitis: a randomized placebo-controlled clinical trial. | 2016 | J Investig Clin Dent | pmid:25044531 |
| EmiralioÄŸlu N et al. | Long term azithromycin therapy in patients with cystic fibrosis. | 2016 | Turk. J. Pediatr. | pmid:27922234 |
| Mougari F et al. | Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. | 2016 | Expert Rev Anti Infect Ther | pmid:27690688 |
| Liu B et al. | Relationship between Community Drug Administration Strategy and Changes in Trachoma Prevalence, 2007 to 2013. | 2016 | PLoS Negl Trop Dis | pmid:27385309 |
| Long SS | Optimizing antimicrobial therapy in children. | 2016 | J. Infect. | pmid:27263076 |
| Farrell DJ et al. | Results from the Solithromycin International Surveillance Program (2014). | 2016 | Antimicrob. Agents Chemother. | pmid:27044551 |
| Mathew JL et al. | Oral Azithromycin for Acute Episodic Airway Symptoms in Young Children: Evidence-based Medicine Viewpoint. | 2016 | Indian Pediatr | pmid:27029689 |
| Pavlović D and Mutak S | Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens. | 2016 | Bioorg. Med. Chem. | pmid:26860929 |
| Narayanasamy DK et al. | Clinico - Laboratory Profile of Scrub Typhus - An Emerging Rickettsiosis in India. | 2016 | Indian J Pediatr | pmid:27352842 |
| Hazra A | Author Reply. | 2016 Jan-Feb | Indian J Pharmacol | pmid:26997735 |
| Das S and Mohanty M | Comparative evaluation of 2 g single dose versus conventional dose azithromycin in uncomplicated skin and skin structure infections. | 2016 Jan-Feb | Indian J Pharmacol | pmid:26997734 |
| Das A et al. | Azithromycin induced bullous fixed drug eruption. | 2016 Jan-Feb | Indian J Pharmacol | pmid:26997729 |
| Chatterjee S et al. | Azithromycin susceptibility among clinical isolates of Salmonella: Interfacing guidelines with routine practices. | 2016 Jul-Sep | Indian J Med Microbiol | pmid:27514976 |
| Latif SA et al. | Azithromycin buccal patch in treatment of chronic periodontitis. | 2016 Mar-Apr | Indian J Pharmacol | pmid:27127325 |
| Oliveira IS et al. | Evaluation of the improvement of quality of life with Azithromycin in the treatment of eosinophilic nasal polyposis. | 2016 Mar-Apr | Braz J Otorhinolaryngol | pmid:26601998 |
| Akoglu G et al. | Erlotinib-induced purpuric papulopustular eruption treated with pulsed azithromycin. | 2016 May-Jun | Indian J Pharmacol | pmid:27298507 |
| Diniz LM et al. | Bacillary angiomatosis with bone invasion. | 2016 Nov-Dec | An Bras Dermatol | pmid:28099606 |
| Zhang M et al. | Electrophysiologic Studies on the Risks and Potential Mechanism Underlying the Proarrhythmic Nature of Azithromycin. | 2017 | Cardiovasc. Toxicol. | pmid:28213753 |
| Lahra MM et al. | Treatment guidelines after an outbreak of azithromycin-resistant Neisseria gonorrhoeae in South Australia. | 2017 | Lancet Infect Dis | pmid:28134103 |
| Yang Z et al. | Azithromycin Causes a Novel Proarrhythmic Syndrome. | 2017 | Circ Arrhythm Electrophysiol | pmid:28408648 |
| Doan T et al. | Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial. | 2017 | Clin. Infect. Dis. | pmid:28402408 |
| Husein-ElAhmed H | Single nontender ulcer on the glans. | 2017 | J Fam Pract | pmid:28375399 |
| McConnell K and Shields M | Azithromycin for episodes with asthma-like symptoms in young children aged 1-3 years. | 2017 | Arch Dis Child Educ Pract Ed | pmid:28735295 |
| Gibson PG et al. | Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. | 2017 | Lancet | pmid:28687413 |
| Molefe NI et al. | Oral administration of azithromycin ameliorates trypanosomosis in Trypanosoma congolense-infected mice. | 2017 | Parasitol. Res. | pmid:28674747 |
| West SK et al. | Treating village newcomers and travelers for trachoma: Results from ASANTE cluster randomized trial. | 2017 | PLoS ONE | pmid:28662043 |
| Johnson SR et al. | Use of whole-genome sequencing data to analyze 23S rRNA-mediated azithromycin resistance. | 2017 | Int. J. Antimicrob. Agents | pmid:28038960 |
| Sanders AM et al. | Burden of trachoma in five counties of Eastern Equatoria state, South Sudan: Results from population-based surveys. | 2017 | PLoS Negl Trop Dis | pmid:28614375 |
| Allen G | Evidence appraisal of Tita ATN, Szychowski JM, Boggess K, et al. Adjunctive azithromycin prophylaxis for cesarean delivery.: N Engl J Med. 2016;375:1231-1241. | 2017 | AORN J | pmid:28034388 |
| Jiang FX et al. | Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance. | 2017 | BMC Infect. Dis. | pmid:28545411 |
| Park J et al. | Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense. | 2017 | Clin. Infect. Dis. | pmid:28011609 |
| Karalius VP et al. | Bordetella parapertussis outbreak in Southeastern Minnesota and the United States, 2014. | 2017 | Medicine (Baltimore) | pmid:28514288 |
| Read TR et al. | Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance. | 2017 | Clin. Infect. Dis. | pmid:28011607 |
| Szczepanska B et al. | Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas. | 2017 | BMC Microbiol. | pmid:28376713 |
| Kawamura K et al. | Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study. | 2017 | BMC Pulm Med | pmid:28629448 |
| Nozawa H et al. | Pertussis without apparent cough in a disabled girl with a tracheostomy. | 2017 | J. Infect. Chemother. | pmid:28623110 |
| Tsubouchi K et al. | Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4. | 2017 | Autophagy | pmid:28613983 |
| Smith KS et al. | Biological and Behavioral Factors Associated With Positive Chlamydia Retests. | 2017 | Sex Transm Dis | pmid:28608791 |
| Wind CM et al. | Decreased Azithromycin Susceptibility of Neisseria gonorrhoeae Isolates in Patients Recently Treated with Azithromycin. | 2017 | Clin. Infect. Dis. | pmid:28510723 |
| Manesh A et al. | A case of clinical and microbiological failure of azithromycin therapy in Salmonella enterica serotype Typhi despite low azithromycin MIC. | 2017 | Int. J. Infect. Dis. | pmid:27894983 |
| Jakubů V et al. | Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015. | 2017 | Cent. Eur. J. Public Health | pmid:29346850 |
| Jover-GarcÃa J et al. | [In-vitro activity of azithromycin in faecal isolates of Aeromonas hydrophila]. | 2017 | An Pediatr (Barc) | pmid:27686393 |
| Menzel M et al. | Azithromycin augments rhinovirus-induced IFNβ via cytosolic MDA5 in experimental models of asthma exacerbation. | 2017 | Oncotarget | pmid:28415826 |
| Kneidinger N et al. | Lung volumes predict survival in patients with chronic lung allograft dysfunction. | 2017 | Eur. Respir. J. | pmid:28404648 |
| Venekamp RP and Schilder AGM | Clinical failure is more common in young children with acute otitis media who receive a short course of antibiotics compared with standard duration. | 2017 | Evid Based Med | pmid:28404603 |
| Ma Q et al. | A Waterborne Outbreak of Shigella sonnei with Resistance to Azithromycin and Third-Generation Cephalosporins in China in 2015. | 2017 | Antimicrob. Agents Chemother. | pmid:28373192 |
| Castelli G et al. | PURLs: Does azithromycin have a role in cesarean sections? | 2017 | J Fam Pract | pmid:29202146 |
| Skeith AE et al. | Adding Azithromycin to Cephalosporin for Cesarean Delivery Infection Prophylaxis: A Cost-Effectiveness Analysis. | 2017 | Obstet Gynecol | pmid:29112658 |
| Stanbrook MB | Azithromycin reduced exacerbations and improved QoL in symptomatic asthma despite inhaled maintenance therapy. | 2017 | Ann. Intern. Med. | pmid:29049761 |